A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening

Area of Science:

• Biotechnology
• Cancer Research
• Biomaterials

Background:

• Most anticancer drug candidates fail in preclinical trials due to inadequate models.
• Current 3D cell cultures lack native extracellular matrix (ECM) properties, limiting biological relevance.
• Existing models do not fully recapitulate the tumor microenvironment's complexity.

Purpose of the Study:

• To develop a novel tissue matrix scaffold (TMS) system using native ECM.
• To create a 3D culture model that better mimics the in vivo tumor microenvironment.
• To improve the accuracy of preclinical cancer drug screening.

Main Methods:

• Fabrication of a reconstitutable tissue matrix scaffold (TMS) system from native tissue ECM.
• Utilizing a combination of porous and hydrogel TMS for compartmental cell culture.
• Assessing cell behavior (survival, proliferation, migration, invasion) and drug response in vitro.
• Evaluating tumor formation and vascularization in vivo.

Main Results:

• The TMS system demonstrated tissue-like architecture and resilience.
• TMS supported robust cell survival, proliferation, migration, and invasion.
• The model facilitated compartmental culture of cancer and stromal cells.
• Drug response in TMS cultures closely reflected animal and clinical observations.
• TMS enabled vascularized tumor formation in vivo.

Conclusions:

• The native ECM-based TMS system provides a more biologically relevant 3D model for cancer research.
• TMS enhances the predictive accuracy of preclinical drug screening.
• This advanced scaffold system is suitable for studying cancer biology and testing therapeutic agents.